< Back to previous page
Researcher
Kristl Claeys
- Disciplines:Neurosciences, Biological and physiological psychology, Cognitive science and intelligent systems, Developmental psychology and ageing
Affiliations
- Laboratory for Muscle Diseases and Neuropathies (Lab)
Responsible
From1 Dec 2016 → Today - Laboratory for Muscle Diseases and Neuropathies (Lab)
Member
From1 Dec 2016 → Today - Research Group Experimental Neurology (Division)
Member
From1 Jan 2016 → 30 Nov 2016
Projects
1 - 6 of 6
- Engelstalig: precision medicine en care in patients neuromuscular dystrophyFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Evaluating novel radiological and clinical outcome measures in hereditary neuromuscular diseases.From1 Jun 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Mass spectrometry-based autoantibody tests for specific diagnosis of autoimmune diseasesFrom1 Oct 2020 → 30 Sep 2022Funding: IOF - technology validation in lab
- TOWARDS TRIAL READINESS IN HEREDITARY NEUROMUSCULAR DISEASES: Developing accurate, feasible and non-invasive outcome measures.From1 Oct 2019 → 1 Oct 2023Funding: FWO fellowships
- Immune profiling of neurological diseases (IPoN)From1 Aug 2018 → 1 Oct 2023Funding: FWO fellowships
- A comprehensive study of genetic determinants of motor neuron vulnerabilityFrom1 Oct 2017 → 2 May 2022Funding: FWO fellowships
Publications
1 - 10 of 176
- Lessons for future clinical trials in adults with Becker muscular dystrophy: Disease progression detected by muscle magnetic resonance imaging, clinical and patient-reported outcome measures(2024)
Authors: Liesbeth De Waele, Kristl Claeys
- Digenic inheritance involving a muscle-specific protein kinase and the giant titin protein causes a skeletal muscle myopathy.(2024)
Authors: Kristl Claeys
Pages: 395 - 407 - EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders(2024)
Authors: Kristl Claeys
- Editorial: Implementing new technologies for neuromuscular disorders(2024)
Authors: Kristl Claeys
- Novel OBSCN variants associated with a risk to exercise-intolerance and rhabdomyolysis(2024)
Authors: Kristl Claeys
Pages: 83 - 88 - Data (gold) mining in genomic databases subsequent to intensive prospective bibliographic monitoring: a substantial diagnostic rate(2024)
Authors: Kristl Claeys
Pages: 285 - 286 - Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP-mediated disease reveals characteristic features useful for diagnosis(2023)
Authors: Kristl Claeys
Pages: 5849 - 5865 - Identify genetic modifiers controlling severity of collagen-6 related dystrophies (COL6-RD)(2023)
Authors: Kristl Claeys
Pages: S158 - S158 - Effect size analysis of cipaglucosidase alfa plus miglustat versus alglucosidase alfa in ERT-experienced adults with late-onset Pompe disease in PROPEL(2023)
Authors: Kristl Claeys
Pages: S151 - S151 - Histopathological features and autophagy aspects of Ku plus myositis(2023)
Authors: Kristl Claeys
Pages: S94 - S94